In a phase II trial, adults with a BMI of 30 or 27 kg/m with comorbidities were randomized to receive efpeglenatide at doses of 4 mg weekly, 6 mg weekly, 6 mg biweekly, or 8 mg biweekly, or a placebo, all combined with a hypocaloric diet [17]
PT-141 is the chemical compound supplied for in vitro research use only and is not an approved pharmaceutical
zuPOO is marketed for gut support and as a colon cleanser for weight management
Manufactured by Hetero Healthcare Pvt Ltd, it is indicated for conditions such as alcoholic liver disease, liver cirrhosis, liver damage in HIV/HCV co-infection, and gastritis
This, in turn, as a tremendous impact on everything from cognitive function to wound healing, the immune response, growth hormone secretion, weight gain, bone structure, and cardiovascular health
BPC-157 is a synthetic chain of 15 amino acids